OCGN News & Events

Latest data shows the largest indicative borrow rate increases among liquid option names include: Yellowstone Midco Holdings Ii, Llc (YSS) 18.35% +1.98, Vivopower Plc (VIVO) 15.14% +1.19, New Fortress Energy (NFE) 19.86% +0.95, Merlin Inc (MRLN) 38.55% +0.67, WhiteFiber Inc (WYFI) 9.26% +0.51, Starfighters Space, Inc. (FJET) 71.88% +0.39, GraniteShares 1.5x Long COIN Daily ETF (CONL) 11.23% +0.38, Outlook Therapeutics Inc (OTLK) 29.93% +0.35, Ocugen (OCGN) 1.23% +0.34, and BioSig Technologies Inc (STEX) 6.85% +0.32.

Reports Q1 revenue $1.53M, consensus $358,140. "In the first few months of 2026, we have completed enrollment of two of our late-stage programs and are diligently working toward initiating our first BLA submission for RP and registration trial for dry AMD later this year," said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. "We are executing well against our plans with the highest productivity per employee rate compared to our peers, adequate cash runway with the recent offering, and key milestone achievement to create long-term value creation for our patients and shareholders."

Ocugen announced its intention to offer, subject to market conditions and other factors, $115M aggregate principal amount of convertible senior notes due 2034 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.